Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Beauty Press Releases.
Press releases published on July 10, 2025
Marble Slab Creamery Celebrates National Ice Cream Day and Ice Cream Month with Cool Surprises
GlobeNewswire
·
July 10, 2025
Homemade Ice Cream Franchise Rewards Loyalty Members with Free Ice Cream and More this July LOS ANGELES, July 10, 2025 (GLOBE NEWSWIRE) -- Marble Slab Creamery, FAT Brands’ small-batch ice cream franchise that never fails to dream up imaginative flavor …
Swiftly and Circle K Launch Nation’s Largest Convenience Retail Alcohol Cashback Program, Opening a New Path to Digital Growth
GlobeNewswire
·
July 10, 2025
SEATTLE , July 10, 2025 (GLOBE NEWSWIRE) -- Swiftly, a leading provider of innovative retail technology tools and solutions, today announced the rollout of the largest alcohol cashback program in U.S. convenience retail, in partnership with Circle K, a …
NFL MVP and Pistachio Farmer Josh Allen Teams with Wonderful Pistachios as the Brand’s New Spokesman and Star of Fall Commercial Campaign
GlobeNewswire
·
July 10, 2025
LOS ANGELES, July 10, 2025 (GLOBE NEWSWIRE) -- Wonderful® Pistachios has announced a major partnership with Buffalo Bills star quarterback and pistachio farmer Josh Allen, uniting the NFL’s reigning Most Valuable Player with America’s #1 Nut brand. A …
Enthusiast Gaming Announces Debt Financing, Forbearance Transaction and Strategic Review Process
GlobeNewswire
·
July 10, 2025
TORONTO, July 10, 2025 (GLOBE NEWSWIRE) -- Enthusiast Gaming Holdings Inc. (TSX: EGLX) (“Enthusiast Gaming” or the “Company”) today announces a debt financing and forbearance transaction (the “Transaction”) designed to support the Company’s …
Calidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to Transform Landscape of Cancer Treatment
GlobeNewswire
·
July 10, 2025
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Calidi Biotherapeutics Inc. (NYSE American: CLDI) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN ( …
K Wave Media (NASDAQ: KWM) Secures $1 Billion Capital Capacity to Drive Bitcoin Treasury Strategy; Announces $500 M Convertible Note with Anson Funds
GlobeNewswire
·
July 10, 2025
NEW YORK and SEOUL, South Korea, July 10, 2025 (GLOBE NEWSWIRE) -- K Wave Media Inc. (Nasdaq: KWM) (“K Wave” or the “Company”), the first Nasdaq-listed public company to integrate Korean cultural content with a Bitcoin-focused corporate treasury model, …
Scality Named Storage Magazine Enterprise Backup Software Vendor and Storage Product of the Year, 2025
GlobeNewswire
·
July 10, 2025
SAN FRANCISCO, July 10, 2025 (GLOBE NEWSWIRE) -- Scality, a global leader in cyber-resilient storage software for the AI era, announced today that it captured two coveted trophies at the 2025 Storage Awards, also known as “The Storries,” taking home …
Acumen Pharmaceuticals to Present Studies on Cost Savings Associated with Use of pTau217 Screening Assay in Phase 2 ALTITUDE-AD Study and Sabirnetug Oligomer-Selectivity at the Alzheimer’s Association International Conference (AAIC®) 2025
GlobeNewswire
·
July 10, 2025
NEWTON, Mass., July 10, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s …
Maxus Mining Announces 2025 Exploration Program at its Penny Copper Project
GlobeNewswire
·
July 10, 2025
VANCOUVER, British Columbia, July 10, 2025 (GLOBE NEWSWIRE) -- Maxus Mining Inc. (“Maxus” or the “Company”) (CSE: MAXM | FRA: R7V), is pleased to provide a summary of the 2025 exploration program (the “Program”) planned on its Penny Copper Project (the “ …
PDS Biotech Announces Colorectal Cancer Cohort of Phase 2 Clinical Trial with PDS01ADC Met Criteria for Expansion to Stage 2 Following Positive Stage 1 Results
GlobeNewswire
·
July 10, 2025
PRINCETON, N.J., July 10, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced …
Cocrystal Pharma to Present Data from Phase 1 Study of First-in-Class Norovirus Protease Inhibitor CDI-988 at the 9th International Calicivirus Conference
GlobeNewswire
·
July 10, 2025
BOTHELL, Wash., July 10, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that its first-in-class pan-viral protease inhibitor CDI-988 has been selected for an oral presentation at the 9th International Calicivirus Conference being …
Graham Media Group and Gray Media Launch Emergency Donation Drive For Texas Flood Relief
GlobeNewswire
·
July 10, 2025
ATLANTA, July 10, 2025 (GLOBE NEWSWIRE) -- In response to the devastating floods that swept through Central Texas and the Hill Country, Graham Media Group and Gray Media have joined forces to launch an urgent donation drive supporting local relief and …
Ligand Partner Pelthos Therapeutics Launches ZELSUVMI™
GlobeNewswire
·
July 10, 2025
JUPITER, Fla., July 10, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its partner Pelthos Therapeutics Inc. (NYSE American: PTHS) has commercially launched ZELSUVMI™ (berdazimer) topical gel 10.3%, the …
Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody
GlobeNewswire
·
July 10, 2025
ISB 2001 is currently in Phase 1 clinical trial in patients with relapsed/refractory multiple myeloma (R/R MM) NEW YORK and NORTH CHICAGO, Ill., July 10, 2025 (GLOBE NEWSWIRE) -- IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos …
Habit Burger & Grill Celebrates Launch of Lake Elsinore Restaurant
GlobeNewswire
·
July 10, 2025
IRVINE, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Habit Burger …
Pharvaris Updates Timing of Topline Data Announcement for RAPIDe-3 Pivotal Phase 3 Study to the Fourth Quarter of 2025
GlobeNewswire
·
July 10, 2025
ZUG, Switzerland, July 10, 2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to address unmet needs of those living with bradykinin-mediated diseases such as …
Parsons Celebrates Infrastructure Excellence in Missouri with Award on I-270 Project
GlobeNewswire
·
July 10, 2025
CHANTILLY, Va., July 10, 2025 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) is proud to announce that its role as lead designer for the I-270 North Design-Build Project has been honored with the prestigious Engineering Excellence Award by the …
Rhythm Pharmaceuticals, Inc. Announces Pricing of Upsized Public Offering of Common Stock
GlobeNewswire
·
July 10, 2025
BOSTON, July 10, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) (“Rhythm”), a global, commercial-stage biopharmaceutical company dedicated to transforming the lives of patients living with rare neuroendocrine diseases, today announced …
CEE Announces Medalists at USA Biolympiad National Finals at Harvard
GlobeNewswire
·
July 10, 2025
MCLEAN, Va. and CAMBRIDGE, Mass., July 10, 2025 (GLOBE NEWSWIRE) -- The Center for Excellence in Education (CEE) today announced the high school biology scholars who earned medals at the USA Biolympiad (USABO) National Finals held at Harvard University in …
New Report Reveals Alarming and Widespread Shortage of Local Journalists Across the U.S.
GlobeNewswire
·
July 10, 2025
MIAMI and BROOKLYN, July 10, 2025 (GLOBE NEWSWIRE) -- The Local Journalist Index is a landmark study by Muck Rack, the trusted platform for journalists and communications professionals, and Rebuild Local News, the leading nonpartisan organization advancing …